Loading...

OPTIMIZING NON-ADDICTIVE DRUG DELIVERY WORLDWIDE

IN THE MANAGEMENT OF PAIN AND CNS DISORDERS

Virpax Pharmaceuticals specializes in developing novel and proprietary drug-delivery systems across various pain and CNS disorder indications to enhance compliance and to optimize the efficacy of each product candidate.

Our transforming drug-delivery platforms and their targeted drug-releasing capabilities have been developed to optimize the efficacy of our non-addictive pain management pipeline and our CNS disorder pipeline.

Targeting pain at its source

Virpax® Pharmaceuticals (Nasdaq: VRPX) is a publicly held specialty pharmaceutical company located in Berwyn, PA and is focused on advancing the development and worldwide commercialization of its non-addictive pain and neurological disorder pipeline.

OPTIMIZING DRUG-DELIVERY

In the Treatment of Pain and CNS Disorders

Envelta spray icon

Envelta™

Molecular Envelope Enkephalin Powder

Envelta is an intranasal enkephalin powder formulation being studied to manage severe post cancer pain and non-cancer pain without the concerns of dependence, respiratory depression, and tolerance compared to morphine.

More about Envelta
Probudur injection icon

Probudur™

Injectable liposomal hydrogel Bupivacaine

Virpax will introduce its proprietary Probudur, a single injectable liposomal gel local anesthetic for postoperative pain management. Probudur will be the only liposomal gel bupivacaine with 96 hours of postoperative pain control; longer than any other liposomal bupivacaine.

More about Probudur
VRP324 spray icon

VRP324

Molecular Envelope Cannabidiol Powder

VRP324 is a pharmaceutical-grade cannabidiol intranasal spray being studied for the management of Epilepsy in adults and children, a Rare Pediatric Disease.

More about VRP324
Epoladerm spray bottle

Epoladerm™

Topical Diclofenac Spray Film

Epoladerm nonclinical studies have demonstrated improved drying times and less messy handling compared to topical gels/ointments. It’s an invisible application, therefore, more aesthetically appealing. Its pliable application allows for optimized use on contours of the knees.

More about Epoladerm

We are pairing effective medical treatments with our transforming drug-delivery platforms

Virpax’s proprietary pipeline is well positioned to meet unmet needs in multi-billion dollar markets.

View our pipeline
Pipeline graphic

Recent Press Releases

VIEW MORE

Recent Media

  • Jul 28, 2022

  • Jun 27, 2022

  • Apr 27, 2022

VIEW MORE

OUR MISSION

Our mission is to use our proprietary delivery systems to optimize the efficacy of our non‑addictive pain and CNS disorder product candidates. 

We want to provide healthcare professionals and patients with effective solutions to manage pain and neurological disorders worldwide.

“We’ve continued to support development of novel non-addictive treatments for pain, including non-opioid analgesics and medical devices.”

ROBERT CALIFF

FDA Commissioner
CalloutWE'RE WORKING TOADVANCE NON-ADDICTIVE DRUG DELIVERY WORLDWIDE

Experienced

executive leadership
Learn more

Robust

pipeline
Learn more
virpax pharma pain management mission

Explore our

Mission

new pain management solutions

Discover our

Products

Pain Management - Team

Meet our

Team

virpax pharmaceutical contact

Let’s

Connect